MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth
Authors:
Open Access
- 5 December 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (3) , 3365-3378
Abstract
MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growthKeywords
This publication has 59 references indexed in Scilit:
- MAGE-A1 promotes melanoma proliferation and migration through C-JUN activationBiochemical and Biophysical Research Communications, 2016
- Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancerAutophagy, 2015
- Degradation of AMPK by a Cancer-Specific Ubiquitin LigaseCell, 2015
- MAGE-A family: Attractive targets for cancer immunotherapyVaccine, 2011
- Melanoma-associated antigen genes – An updateCancer Letters, 2011
- When MAGE meets RING: insights into biological functions of MAGE proteinsProtein & Cell, 2011
- MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin LigasesMolecular Cell, 2010
- The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and MetastasisCancer Research, 2008
- Cancer/testis antigens, gametogenesis and cancerNature Reviews Cancer, 2005
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991